Featured Publications

Valdearcos, Martin, et al. “Microglial Inflammatory Signaling Orchestrates the Hypothalamic Immune Response to Dietary Excess and Mediates Obesity Susceptibility”. 2017. Cell Metabolism, vol. 26, no. 1, 2017, pp. 185–197.e3.

Emmett, Matthew J, et al. “Histone Deacetylase 3 Prepares Brown Adipose Tissue for Acute Thermogenic Challenge”. 2017. Nature, vol. 546, no. 7659, 2017, pp. 544–548.

Dean, Danielle, et al. “Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation”. 2017. Cell Metabolism, vol. 25, no. 6, 2017, pp. 1362–1373.e5.

Brar, Gurkirat S, et al. “Neprilysin Is Required for Angiotensin-(1-7)’s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2)”. 2017. Diabetes, vol. 66, no. 8, 2017, pp. 2201–2212.

Irimia, Jose M, et al. “Lack of Liver Glycogen Causes Hepatic Insulin Resistance and Steatosis in Mice”. 2017. The Journal of Biological Chemistry, vol. 292, no. 25, 2017, pp. 10455–10464.

Sassoon, Daniel J, et al. “Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction”. 2017. Diabetes, vol. 66, no. 8, 2017, pp. 2230–2240.

Støy, Julie, et al. “In Vivo Measurement and Biological Characterisation of the Diabetes-Associated Mutant Insulin p.R46Q (GlnB22-insulin)”. 2017. Diabetologia, vol. 60, no. 8, 2017, pp. 1423–1431.

Zhang, Yalin, et al. “Astrocytic Process Plasticity and IKKβ NF-κB in Central Control of Blood Glucose, Blood Pressure, and Body Weight”. 2017. Cell Metabolism, vol. 25, no. 5, 2017, pp. 1091–1102.e4.

Guo, Fangjian, and Timothy Garvey. “Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine Topiramate Extended Release”. 2017. Diabetes Care, vol. 40, no. 7, 2017, pp. 856–862.

Li, Changhong, et al. “Functional and Metabolomic Consequences of K Channel Inactivation in Human Islets”. 2017. Diabetes, vol. 66, no. 7, 2017, pp. 1901–1913.

Qi, Weier, et al. “Pyruvate Kinase M2 Activation May Protect Against the Progression of Diabetic Glomerular Pathology and Mitochondrial Dysfunction”. 2017. Nature Medicine, vol. 23, no. 6, 2017, pp. 753–762.